statistiche ricercatore

MAGGI, FABRIZIO

Distribuzione geografica

Continente	#
NA - Nord America	8.656
EU - Europa	3.807
AS - Asia	810
Continente sconosciuto - Info sul continente non disponibili	8
SA - Sud America	7
OC - Oceania	5
Totale	13.293

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	8.648
IT - Italia	1.322
IE - Irlanda	869
VN - Vietnam	689
SE - Svezia	563
DE - Germania	427
UA - Ucraina	347
GB - Regno Unito	143
JP - Giappone	51
FR - Francia	47
FI - Finlandia	28
IN - India	27
BE - Belgio	16
CN - Cina	12
CZ - Repubblica Ceca	11
NL - Olanda	9
SG - Singapore	8
CA - Canada	7
EU - Europa	7
IL - Israele	5
AU - Australia	4
BG - Bulgaria	4
TR - Turchia	4
AR - Argentina	3
BR - Brasile	3
ES - Italia	3
HK - Hong Kong	3
LK - Sri Lanka	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
HR - Croazia	2
LT - Lituania	2
PT - Portogallo	2
RO - Romania	2
TH - Thailandia	2
A2 - ???statistics.table.value.countryCode.A2???	1
BT - Bhutan	1
CH - Svizzera	1
CL - Cile	1
CR - Costa Rica	1
DK - Danimarca	1
EE - Estonia	1
GR - Grecia	1
HU - Ungheria	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PH - Filippine	1
PK - Pakistan	1
PL - Polonia	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
Totale	13.293

Salva come PNG Salva come JPEG

Città	#
Fairfield	1.291
Ashburn	986
Jacksonville	962
Dublin	856
Milan	841
Princeton	739
Chandler	651
Wilmington	616
Woodbridge	490
Nyköping	439
Houston	427
Seattle	415
Cambridge	381
Dong Ket	334
Redwood City	176
San Diego	173
Ogden	143
Ann Arbor	139
Washington	123
New York	91
Como	67
Rome	67
London	54
Tokyo	51
Norwalk	47
Los Angeles	34
Frankfurt am Main	25
Kilburn	18
Helsinki	17
Brussels	14
Berlin	12
Redmond	12
Chiswick	11
Rio Saliceto	11
Varese	11
Boardman	10
Lappeenranta	10
Pune	10
Brno	8
Concorezzo	7
Inverigo	7
Singapore	7
Acton	6
Beijing	6
Groningen	6
Napoli	6
Prescot	6
Busto Arsizio	5
Catania	5
Chicago	5
Laxou	5
Lovere	5
Vicenza	5
Gavirate	4
Hounslow	4
New Bedfont	4
Sofia	4
Southwark	4
Sovicille	4
Tel Aviv	4
Wandsworth	4
Amsterdam	3
Falkenstein	3
San Francisco	3
San Giuliano Terme	3
San Mateo	3
Solbiate Olona	3
Toronto	3
Vicopisano	3
Atlanta	2
Bangalore	2
Bergamo	2
Cerro Maggiore	2
Cologno Monzese	2
Dubai	2
Fayetteville	2
Florence	2
Gent	2
Gunzenhausen	2
Istanbul	2
Kandy	2
Kocaeli	2
Lecce	2
Lisbon	2
Melbourne	2
Menlo Park	2
Miami Beach	2
Mountain View	2
Noci	2
Paris	2
Pistoia	2
Posadas	2
Prague	2
Rimini	2
Rozzano	2
Seriate	2
Serra	2
Springfield	2
Taurisano	2
Vancouver	2
Totale	10.961

Salva come PNG Salva come JPEG

Nome	#
Viral hepatitis	173
Torque Teno virus: any pathological role in liver transplanted patients?	145
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections	140
Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples	138
Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9	124
Immunobiology of the Torque teno viruses and other anelloviruses	103
Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates	102
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	97
Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+NaiVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study	91
Impact of Microbial Metabolites on Microbiota–Gut–Brain Ax-is in Inflammatory Bowel Disease	88
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	88
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon?	87
An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine	87
La vaccinazione con la glicoproteina B del virus Herpes Simplex tipo 1 protegge contro l’herpes genitale	84
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients	83
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients	80
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy	77
Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection	76
Anelloviruses and immune competence	76
SYMPTOMATIC SARS-CoV-2 INFECTIONS AFTER FULL SCHEDULE BNT162b2 VACCINATION IN SEROPOSITIVE HEALTHCARE WORKERS: A CASE SERIES FROM A SINGLE INSTITUTION	76
How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection	75
Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection	75
Sialic acid moieties and 5-HT2a: two faces of the same receptor for JC virus?	74
Zika Virus: Implications for Public Health	74
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19	74
HIV-1 NAT minipool during the pre-seroconversion window period: Detection of a repeat blood donor	72
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients	72
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy	70
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy	70
TTV GUIDE IT - A randomised controlled trial to compare the safety, tolerability and preliminary efficacy between standard and torque teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation - a trial protocol	70
Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin	68
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	66
During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein	62
Absence of xenotropic murine leukemia virus-related virus in italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis	62
Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy	62
High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs	60
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody	60
Monitoring Human Immune Competence Using a Symbiont Virus: From Bench to Bedside	59
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study	58
Is a single COVID-19 vaccine dose enough in convalescents ?	56
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy	56
Valutazione della presenza di immunocomplessi circolanti in pazienti HCV positivi	55
Sialic acid moieties and 5-HT(2a): Two faces of the same receptor for JC virus?	55
Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon alpha	55
Kinetics of anti-SARS-COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability	55
5-HT2a antagonists as a new treatment for JCV-associated progressive multifocal leukoencephalopathy	54
Combination therapy with interferon alpha and ribavirin in interferon alpha relapsers	54
TT virus in the nasal secretions of children with acute respiratory diseases: Relations to viremia and disease severity	54
Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies	54
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021	54
The Virome and its Major Component, Anellovirus, a Convoluted System Molding Human Immune Defenses and Possibly Affecting the Development of Asthma and Respiratory Diseases in Childhood	53
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease	53
TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases	53
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy	53
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children	52
Anellovirus	52
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: Old drugs for an old disease	52
Lack of association of mixed cryoglobulinemia with transfusion transmitted virus (TTV)	51
Expression of MxA mRNA in PBL from chronic hepatitis C patients and response to interferon-alpha therapy	51
Anellovirus	51
Human anelloviruses and the central nervous system	51
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study	51
Anellovirus	50
Hyaluronan: A neuroimmune modulator in the microbiota-gut axis	50
A novel rolling circle amplification assay to detect members of the family Anelloviridae in pigs and humans	49
Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer	49
Immunosuppressive monoclonal antibodies: current and next generation	48
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients	48
Emergence of exhausted B and T cells in asymptomatic HIV-1-infected patients naive for HAART is related to reduced immune surveillance	47
Anellovirus e virus simili	47
Genetic heterogeneity of hepatitis C virus: quasispecies analysis in liver, peripheral blood mononuclear cells and plasma	47
Effects of Toll like receptor-9 ligands on human pancreatic cells	47
Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects	47
Anellovirus	46
Il viroma: un nuovo concetto d'interazione virus-ospite	46
Anellovirus	46
Role of Hematopoietic Cells in the Maintenance of Chronic Human Torquetenovirus Plasma Viremia	46
A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers	46
How multiplex testing approach to respiratory viruses detection can enhance influenza surveillance	46
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022	45
Torquetenovirus viremia kinetics as a novel marker of functional immune deficiency in solid organ transplantation	45
Chronic hepatitis C virus infection in dialysis: relevance of anti-HCV IgM antibodies	45
In vivo MxA mRNA expression as predictive marker of response to IFN alpha in chronic active hepatitis C patients	45
Getting the most from the Ebola vaccine success	45
TT virus infection of periodontal tissues: A controlled clinical and laboratory pilot study	45
Torquetenovirus infection and ciliary dysmotility in children with recurrent pneumonia	45
Cell therapies for treatment of human immunodeficiency virus infection	45
Analysis of immune escape variants from antibody‐based therapeutics against covid‐19: A systematic review	45
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes	45
Anellovirus	44
Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation	43
Assessment of prevalence and load of torquetenovirus viremia in a large cohort of healthy blood donors	43
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus (TTV) viremia, the new surrogate marker of immune competence	43
Hepatitis C virus serological and polymerase chain reactions in human immunodeficiency virus-positive and -negative patients	43
COVID-19 emergency management: From the reorganization of the endoscopy service to the verification of the reprocessing efficacy	43
Attempt to classify the clinical impact of DNA viruses according to the ability to activate the innate immune system	42
Lymphotropic polyomavirus and progressive multifocal leukoencephalopathy	42
TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathologies	41
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders	41
Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy	41
Totale	6.244

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	91.123
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	91.123

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	5.500	0	0	0	0	0	2.070	530	619	712	247	400	922
2021/2022	2.928	242	387	65	114	52	129	181	232	166	574	298	488
2022/2023	2.588	443	148	149	151	81	639	30	256	370	195	58	68
2023/2024	2.817	227	229	252	564	568	483	46	78	217	46	16	91
2024/2025	8	8	0	0	0	0	0	0	0	0	0	0	0
Totale													13.841